Search research articles
Contact Us
Filters
Showing results (21-30 of 55) with videos related to
Page
of 6
Sort By:
Cancers
|
March 29, 2023
Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma
Colton Ladbury, Savita Dandapani, Claire Hao, et al.
Research Square
|
May 18, 2026
Cyclin-Dependent Kinase 5 Contributes to Bruton's Tyrosine Kinase Inhibitor Resistance via the IRE1α/XBP1 Axis in Mantle Cell Lymphoma
Alexey Danilov, Sonia Rodriguez-Rodriguez, Dan Vuong, et al.
Annals of Surgery
|
July 13, 2026
Efficacy of Splenectomy for Hematologic Malignancies: A Retrospective Cohort Study
Hamza Mohammed, Muhammad Talha Waheed, Vijay Trisal, et al.
Haematologica
|
July 3, 2025
Safety and efficacyof the combination of copanlisib and nivolumab in patients with Richter's transformation or transformed non-Hodgkin lymphoma: results from a phase I trial
Geoffrey Shouse, Canping Chen, Alexandra Muir, et al.
Haematologica
|
July 18, 2024
Atezolizumab combined with immunogenic salvage chemoimmunotherapy in patients with transformed diffuse large B-cell lymphoma
Tamer Othman, Paul Frankel, Pamela Allen, et al.
Leukemia & Lymphoma
|
August 6, 2025
Real-world infectious complications of CD3/CD20 bispecific antibodies in relapsed/refractory non-Hodgkin lymphoma
Annie Xiao, Lu Chen, Stacy Pak, et al.
American Journal of Hematology
|
September 5, 2023
Bendamustine lymphodepletion is a well-tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B-cell lymphoma
Shin Yeu Ong, Stacy Pak, Matthew Mei, et al.
Blood
|
March 14, 2024
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma
James K Godfrey, Lei Gao, Geoffrey Shouse, et al.
Blood Cancer Journal
|
October 18, 2024
Evaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort study
Natalie S Grover, Kaitlin Annunzio, Marcus Watkins, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 23, 2026
A Phase I Study of Copanlisib and Venetoclax in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Jennifer L Crombie, Austin I Kim, Robert Redd, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 55) with videos related to
Sort By:
Page
of 6
Cancers
|
March 29, 2023
Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma
Colton Ladbury, Savita Dandapani, Claire Hao, et al.
Research Square
|
May 18, 2026
Cyclin-Dependent Kinase 5 Contributes to Bruton's Tyrosine Kinase Inhibitor Resistance via the IRE1α/XBP1 Axis in Mantle Cell Lymphoma
Alexey Danilov, Sonia Rodriguez-Rodriguez, Dan Vuong, et al.
Annals of Surgery
|
July 13, 2026
Efficacy of Splenectomy for Hematologic Malignancies: A Retrospective Cohort Study
Hamza Mohammed, Muhammad Talha Waheed, Vijay Trisal, et al.
Haematologica
|
July 3, 2025
Safety and efficacyof the combination of copanlisib and nivolumab in patients with Richter's transformation or transformed non-Hodgkin lymphoma: results from a phase I trial
Geoffrey Shouse, Canping Chen, Alexandra Muir, et al.
Haematologica
|
July 18, 2024
Atezolizumab combined with immunogenic salvage chemoimmunotherapy in patients with transformed diffuse large B-cell lymphoma
Tamer Othman, Paul Frankel, Pamela Allen, et al.
Leukemia & Lymphoma
|
August 6, 2025
Real-world infectious complications of CD3/CD20 bispecific antibodies in relapsed/refractory non-Hodgkin lymphoma
Annie Xiao, Lu Chen, Stacy Pak, et al.
American Journal of Hematology
|
September 5, 2023
Bendamustine lymphodepletion is a well-tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B-cell lymphoma
Shin Yeu Ong, Stacy Pak, Matthew Mei, et al.
Blood
|
March 14, 2024
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma
James K Godfrey, Lei Gao, Geoffrey Shouse, et al.
Blood Cancer Journal
|
October 18, 2024
Evaluation of Ki-67 expression and large cell content as prognostic markers in MZL: a multicenter cohort study
Natalie S Grover, Kaitlin Annunzio, Marcus Watkins, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 23, 2026
A Phase I Study of Copanlisib and Venetoclax in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Jennifer L Crombie, Austin I Kim, Robert Redd, et al.
Page
of 6